The latest announcement is out from Applied Therapeutics Inc (APLT).
Applied Therapeutics, Inc. has appointed Dale Hooks as the new Chief Commercial Officer, bringing over 30 years of experience and a history of over 20 product launches to the role. Hooks, who previously contributed his expertise to companies like Reata Pharmaceuticals and Genentech, will commence his position with a robust compensation package, including a $525,000 base salary and potential for performance bonuses and equity awards. His predecessor, Adam Hansard, exits with a severance agreement that includes nine months of his base salary and additional benefits.
For a thorough assessment of APLT stock, go to TipRanks’ Stock Analysis page.
